Skip to main content

Table 5 The medicine and endoscopic treatments for EPS

From: Esophageal papillomatosis: an exceedingly rare disease

 

Source

Methods

Outcome

Medicine

   

PPI

Pasman et al. [37]

N

Inefficacy

 

Gencdal et al. [68]

N

Improvement of symptoms

Alpha-interferon

Hording et al. [25]

4 MIU daily, subcutaneously for 4 weeks, double dose for 2 weeks, 8 MIU three times weekly

Early improvement and subsequent recurrence

 

Van Cutsem et al. [26]

6 × 106 U five times a week for 4 weeks followed by three times a week for 2 months

Recurrence

Vacine

Mészner et al. [7]

Three doses of the quadrivalent HPV vaccine at 0, 2 and 6 months

Elimination

Endoscopy

   

APC

Pasman et al. [37]

ERBE VIO APC system,with an effect of 5

Elimination

Radiofrequency ablation

Romano et al. [28]

The first procedure treatment: the 360° catheter; the second and third treatment: the Barrx Channel catheter at 12 J/cm2

Elimination

Photodynamic therapy

Wolfsen et al. [43]

Infusion of porfimer sodium (2 mg/kg), with endoscopic delivery of 300–400 J/cm fifiber length red light energy (wavelength 630 nm)

Remission

Cryotherapy

McDonald et al. [62]

Liquid nitrogen cryotherapy

Elimination

 

Alomari et al. [66]

Liquid nitrogen cryogen applied for 20 s, 3 sessions, 2–4 months apart

Elimination

Laser therapy

Hording et al. [25]

CO2-laser: 4 times

Inefficacy

 

Tu et al. [65]

Nd:YAG:50 watts, 0.2 s duration, and 0.1 s intervals

Elimination

Local injections of HPMPC cytosine

Van Cutsem et al. [26]

HPMPC 1.25 mg/kg, the first four injections: an interval of 1 week, the next three injections: an interval of 3–5 weeks

Elimination

EMR

Kim et al. [67]

Performed by a band mucosectomy device

Elimination

Dilation

Narayani et al. [14]

Progressive dilation

Temporary improvement and subsequent progression

Saravanan et al. [15]

Repeated dilation

Kao et al. [52]

Repeated dilation

  1. PPI proton pump inhibitor, APC argon plasma coagulation, EMR endoscopic mucosal resection, HPMPC (S)-l-(3-hydroxy-2-phosphonylmethoxypropy1)cytosine, N not mention